MedPath

Effect of simvastatin for chronic glomerulonephritis

Phase 2
Conditions
chronic glomerulonephritis
Registration Number
JPRN-C000000361
Lead Sponsor
Depertment of Allergy and Rheumatology, University of Tokyo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with other lipid-lowering agents 2. Patients with serum creatinine level higher than 1.6mg/dl

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of proteinuria after administration of simvastatin for 12 weeks
Secondary Outcome Measures
NameTimeMethod
Renal function and immunological findings after administration of simvastatin for 12 weeks
© Copyright 2025. All Rights Reserved by MedPath